These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16123717)

  • 1. Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C.
    Rayhill SC; Kirby PA; Voigt MD; La Brecque DR; Lutz CT; Katz DA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Heisey D; Wu YM; Schmidt WN
    Transplantation; 2005 Aug; 80(4):448-56. PubMed ID: 16123717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation.
    Fortune BE; Martinez-Camacho A; Kreidler S; Gralla J; Everson GT
    Transpl Int; 2015 Aug; 28(8):980-9. PubMed ID: 25818896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort.
    Belli LS; Romagnoli R; Nardi A; Marianelli T; Donato F; Corradini SG; Iemmolo RM; Morelli C; Pasulo L; Rendina M; De Martin E; Ponziani FR; Volpes R; Strazzabosco M; Angelico M;
    Dig Liver Dis; 2015 Aug; 47(8):689-94. PubMed ID: 26055490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.
    Bahra M; Jacob D; Neumann UP; Spies F; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplantation; 2007 Jul; 84(2):144-8. PubMed ID: 17667804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database.
    Kuo HT; Lum E; Martin P; Bunnapradist S
    Liver Transpl; 2016 Jun; 22(6):796-804. PubMed ID: 26850091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.
    Kim SM; Kim HW; Lee EK; Park SK; Han DJ; Kim SB
    Transplantation; 2013 Jul; 96(1):85-90. PubMed ID: 23632392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of liver grafts procured from hepatitis C-positive donors.
    Velidedeoglu E; Desai NM; Campos L; Olthoff KM; Shaked A; Nunes F; Zeldin G; Stewart C; Blumberg E; Abrams J; Markmann JF
    Transplantation; 2002 Feb; 73(4):582-7. PubMed ID: 11889435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
    Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.
    Ydreborg M; Westin J; Lagging M; Castedal M; Friman S
    Scand J Gastroenterol; 2012 Jun; 47(6):710-7. PubMed ID: 22452366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.
    Dharancy S; Podevin P; Aoudjehane L; Batteux F; Rosenberg AR; Soubrane O; Calmus Y; Conti F
    Transplantation; 2007 Apr; 83(7):906-11. PubMed ID: 17460561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
    Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
    Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic progression of recurrent hepatitis C in liver transplant allografts.
    Greenson JK; Svoboda-Newman SM; Merion RM; Frank TS
    Am J Surg Pathol; 1996 Jun; 20(6):731-8. PubMed ID: 8651353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
    Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
    Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication.
    Whitcomb E; Choi WT; Jerome KR; Cook L; Landis C; Ahn J; Te HS; Esfeh J; Hanouneh IA; Rayhill SC; Gibson W; Plesec T; Koo J; Wang HL; Hart J; Pai RK; Westerhoff M
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1279-1285. PubMed ID: 28501538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.